Drugs (Pharmaceuticals) – Page 3

F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts

Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.

By Christina Jewett

Drugs (Pharmaceuticals) GLP-1 RAs (Drug) Health Insurance and Managed Care Novo Nordisk A/S Prices (Fares, Fees and Rates) Weight

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.

By Rebecca Robbins

American Benefits Council CVS Caremark Corporation DeSantis, Ron Doctors Drugs (Pharmaceuticals) Florida Insurance Law and Legislation Optum Inc pharmacy benefit managers Privacy Regulation and Deregulation of Industry

Florida Seeks Drug Prescription Data With Names of Patients and Doctors

The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy concerns.

By Reed Abelson and Rebecca Robbins

Advertising and Marketing Appointments and Executive Changes Centers for Medicare and Medicaid Services Dietary Supplements and Herbal Remedies Drugs (Pharmaceuticals) Ethics and Official Misconduct Health Insurance and Managed Care Kennedy, Robert F Jr Medicaid Medicare Medicare Advantage Medicine and Health Oz, Mehmet C Presidential Election of 2024 Presidential Transition (US) Regulation and Deregulation of Industry Senate Committee on Finance Stocks and Bonds Trump, Donald J United States Politics and Government UnitedHealth Group Inc

Dr. Oz: How His Millions Collide With Medicare

The TV celebrity and Trump nominee has pledged to divest from most of his financial interests. But they touch nearly every corner of health care, from insurance to blood pressure cuffs and vitamins, leading experts and lawmakers to doubt he could make impartial decisions.

By Reed Abelson and Susanne Craig